bumetanide vs dapagliflozin
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of bumetanide and dapagliflozin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
No dosing adjustments required for the following: Oral Antidiabetic Agents Metformin (1000 mg) 20 mg ↔ ↔ Pioglitazone (45 mg) 50 mg ↔ ↔ Sitagliptin (100 mg) 20 mg ↔ ↔ Glimepiride (4 mg) 20 mg ↔ ↔ Voglibose (0.2 mg three times daily) 10 mg ↔ ↔ Other Medications Hydrochlorothiazide (25 mg) 50 mg ↔ ↔ Bumetanide (1 mg) 10 mg once daily for 7 days ↔ ↔ Valsartan (320 mg) 20 mg ↓12% [↓3%, ↓20%] ↔ Simvastatin (40 mg) 20 mg ↔ ↔ Anti-infective Agent Rifampin (600 mg once daily for 6 days) 10 mg ↓7% [↓22%, ↑11%] ↓22% [↓27%, ↓17%] Nonsteroidal Anti-inflammatory Agent Mefenamic Acid (loading dose of...
Bumex
Farxiga
Bumetanide is a water pill (diuretic). It helps your body get rid of extra water and salt.
Dapagliflozin (Farxiga) helps lower blood sugar in adults with type 2 diabetes. It also helps adults with heart failure or chronic kidney disease.
This medicine treats swelling (edema) caused by heart failure, liver problems, or kidney problems. It helps your body get rid of extra fluid. If you are allergic to furosemide, you may be able to take bumetanide instead.
This medicine can help adults with chronic kidney disease by reducing the risk of kidney problems, heart problems, and needing to go to the hospital for heart failure. It can also help adults with heart failure by reducing the risk of heart problems and needing urgent care for heart failure. For adults with type 2 diabetes, it can help lower the risk of needing to go to the hospital for heart failure.
Bumetanide works in your kidneys to increase the amount of salt and water that you pass in your urine. This helps to lower the amount of fluid in your body. It starts working quickly and does not last very long.
Dapagliflozin is a type of medicine called an SGLT2 inhibitor. It works in the kidneys to remove extra sugar from your body through your urine. This helps to lower your blood sugar levels.
- • Muscle cramps
- • Dizziness
- • Low blood pressure
- • Headache
- • Nausea
- • Yeast infections of the vagina
- • Common cold
- • Urinary tract infections
- Dyspnoea 2,495
- Acute Kidney Injury 1,657
- Death 1,642
- Fatigue 1,639
- Diarrhoea 1,474
- Death 7,017
- Fatigue 2,250
- Nausea 2,218
- Dizziness 2,096
- Diarrhoea 2,074
Bumetanide is a strong diuretic. If you take too much, it can cause you to lose too much water and electrolytes. You need to be carefully watched by your doctor, and your dose needs to be adjusted to fit your needs.
Dapagliflozin can cause a serious condition called diabetic ketoacidosis (DKA), especially if you have type 1 diabetes. Symptoms include nausea, vomiting, stomach pain, and trouble breathing. If you have these symptoms, stop taking this medicine and get medical help right away. This medicine can also cause serious infections in the area between your genitals and anus. Get medical help right away if you have pain, tenderness, redness, or swelling in this area, along with a fever or feeling unwell.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if bumetanide will harm your unborn baby. Talk to your doctor about the risks and benefits of taking bumetanide during pregnancy or while breastfeeding.
This medicine may harm your unborn baby, especially during the second and third trimesters. It is not recommended while breastfeeding.
Also Compare, Nearby Drugs
Compare bumetanide with
Compare dapagliflozin with
How to Read This bumetanide vs dapagliflozin Comparison
bumetanide is classified in the Loop Diuretic drug class, while dapagliflozin sits within the SGLT2 Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, bumetanide has 8,907 submissions while dapagliflozin has 15,655. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to these medications do not significantly change how the other is processed by your body.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for bumetanide or dapagliflozin.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.